Brilinta - Used for: Reducing the risk of stroke, heart attack, or death in certain patients who have had a heart attack or who have angina (chest pain). It should be used along with aspirin as directed by your doctor. It also may be used for other conditions as determined by your doctor.
Brilinta is a platelet aggregation inhibitor. It works by slowing or stopping platelets from sticking to blood vessel walls or injured tissues.
Brilinta keeps the platelets in your blood from coagulating (clotting) to prevent unwanted blood clots that can occur with certain heart or blood vessel conditions.
Brilinta is used to lower your risk of having a stroke or serious heart problems after you have had a heart attack or severe chest pain (angina).
Brilinta may also be used for purposes not listed in this medication guide.
Brilinta is used to reduce the risk of heart attack and stroke in people who have a high risk of getting them. This includes people who have had a heart attack or unstable angina (chest pain that is not well controlled). It also includes people with blood circulation problems that may increase their chances of getting a heart attack or stroke. Brilinta prevents special cells in the blood -- the platelets -- from sticking to each other. This reduces the risk of harmful blood clots forming. Blood clots that form in a blood vessel inside the heart or brain can cause a heart attack or a stroke.
Co-administered with acetylsalicylic acid (ASA) for the prevention of atherothrombotic events in adult patients with acute coronary syndrome (ACS) [unstable angina, non-ST elevation myocardial infarction (NSTEMI) or ST elevation myocardial infarction (STEMI)]; including patients managed medically, and those who are managed with percutaneous coronary intervention (PCI) or coronary artery by-pass graft (CABG).
Brilinta, a platelet inhibitor drug, is indicated for the reduction of thrombotic events associated with acute coronary syndrome, non-ST elevation myocardial infarction and unstable angina. Brilinta can reduce the mortality rate among these patients and comparatively effective than Clopidogrel.